Mitigating the cryoprecipitate shortage by using apheresis plasma as a manufacturing source
Transfusion · 2023
DOI: 10.1111/trf.17335 ↗Kurz gefasst
Leserbrief in der Zeitschrift Transfusion, 2023. Verfasst von Rugved Pattarkine und 3 weiteren Autor:innen. Beteiligte Einrichtung: Wing-Kwai and Alice Lee-Tsing Chung Transfusion Service, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Lo…. Hauptthemen laut MEDLINE: Blood Component Removal. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wing-Kwai and Alice Lee-Tsing Chung Transfusion Service, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
ORCID-Profile: Rugved Pattarkine, Alyssa Ziman, Dawn C Ward
Zitieren
APA
Pattarkine, R., Manansala, A. R., Ziman, A., & Ward, D. C. (2023). Mitigating the cryoprecipitate shortage by using apheresis plasma as a manufacturing source. Transfusion. https://doi.org/10.1111/trf.17335
Vancouver
Pattarkine R, Manansala AR, Ziman A, Ward DC. Mitigating the cryoprecipitate shortage by using apheresis plasma as a manufacturing source. Transfusion. 2023. doi:10.1111/trf.17335
BibTeX
@article{Pattarkine2023,
author = {Pattarkine, Rugved and Manansala, Aida-Rae and Ziman, Alyssa and Ward, Dawn C},
title = {Mitigating the cryoprecipitate shortage by using apheresis plasma as a manufacturing source},
journal = {Transfusion},
year = {2023},
doi = {10.1111/trf.17335}
}
EUVIMED